+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Zinc Finger Nuclease Technology Market by Therapeutics, Functional Genomics, Agriculture, Drug Discovery - Global Forecast to 2030- Product Image
Zinc Finger Nuclease Technology Market by Therapeutics, Functional Genomics, Agriculture, Drug Discovery - Global Forecast to 2030- Product Image
Sale

Zinc Finger Nuclease Technology Market by Therapeutics, Functional Genomics, Agriculture, Drug Discovery - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5460340
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Zinc Finger Nuclease Technology Market grew from USD 905.13 million in 2024 to USD 1.11 billion in 2025. It is expected to continue growing at a CAGR of 22.02%, reaching USD 2.98 billion by 2030.

Pioneering Precision Editing with Zinc Finger Nucleases

Genome editing has reached a pivotal moment with the emergence of zinc finger nuclease technology as a cornerstone for precise DNA modifications. By harnessing engineered proteins that bind to specific genomic loci and introduce double-strand breaks, this platform unlocks therapeutic avenues that were once deemed unattainable. Unlike earlier approaches, zinc finger nucleases combine modular DNA-recognition domains with robust cleavage activity to target even the most challenging genomic regions, delivering a level of specificity and versatility that fosters innovative interventions across medicine, agriculture, and biotechnology.

As stakeholders in this rapidly evolving field seek to translate molecular promise into clinical and commercial success, a holistic understanding of technological, regulatory, and market dynamics becomes imperative. This executive summary illuminates the transformative shifts shaping the landscape, examines regulatory actions influencing cost structures and supply chains, and distills actionable insights from segmentation and regional analyses. By synthesizing the current state and projecting forward-looking imperatives, this overview equips decision-makers with the knowledge to navigate complexities and capitalize on emerging opportunities in zinc finger nuclease-enabled applications.

Shifting Paradigms in Genome Engineering

The genome editing ecosystem is undergoing seismic shifts driven by breakthrough delivery methods, advanced protein engineering, and data-centric validation frameworks. Viral and nonviral vectors have evolved to enable more efficient and less immunogenic cargo delivery, while machine learning algorithms optimize nuclease design by predicting off-target interactions with unprecedented accuracy. Concurrently, the convergence of single-cell sequencing and high-resolution imaging provides real-time insights into editing outcomes, accelerating the refinement of therapeutic candidates.

Regulatory bodies are also recalibrating their frameworks to match the pace of innovation, fostering adaptive pathways that balance safety with expedited access. Collaborative consortia among academic centers, contract research organizations, and industry partners are establishing precompetitive platforms for standardizing assay protocols and sharing best practices. These collective advancements are not only enhancing the reliability of zinc finger nuclease interventions but are also setting new benchmarks for precision, reproducibility, and ethical stewardship in genome engineering.

Navigating the Impact of US Tariffs 2025 on Innovation

In 2025, the enactment of new tariffs on imported reagents, specialized enzymes, and bioprocessing equipment has introduced both headwinds and strategic inflection points for genome editing developers. The increased cost of raw materials has prompted companies to reassess supply chain dependencies, negotiate local manufacturing partnerships, and explore alternative enzyme sources. These adaptations are critical for preserving research budgets and ensuring continuity of preclinical pipelines.

Beyond direct cost implications, tariff-induced delays in equipment shipments have led organizations to adopt just-in-time procurement strategies and bolster in-house production capabilities. As a result, some early-stage ventures have accelerated their collaborations with domestic suppliers, while more established players leverage long-term procurement contracts to hedge against further volatility. This ripple effect underscores the necessity of agile operational models that can absorb policy-driven disruptions while maintaining momentum toward clinical milestones.

Revealing Critical Segmentation Perspectives

Within the therapeutics arena, the market spans chronic diseases, oncology and rare genetic disorders, while oncology is further distinguished by hematologic malignancies and solid tumors, each presenting unique safety considerations and commercial value propositions. In parallel, functional genomics applications are segmented into custom services and research tools, with the latter encompassing both laboratory instruments and critical reagent kits that underpin assay development.

Agricultural applications of zinc finger nucleases have similarly diversified into crop improvement and livestock engineering, held aloft by advances that enhance pest resistance and yield enhancement in crops and drive targeted trait modification in animal breeding programs. Meanwhile, drug discovery initiatives deploy genome editing for both screening platforms and target validation workflows, where high throughput screening and cell based assays work in concert to identify and characterize lead candidates.

Unearthing Regional Market Dynamics

Global dynamics reveal a mosaic of opportunities and challenges across geographies that include the Americas, Europe, Middle East & Africa, and Asia-Pacific, each characterized by distinct regulatory climates, funding landscapes, and talent pools. In the Americas, robust venture capital inflows and a consolidated regulatory pathway have established a vibrant ecosystem where startups and established biopharma compete on speed and specificity of editing platforms. The region’s emphasis on rare disease therapies and hematologic malignancies has driven targeted investments in clinical-stage zinc finger nuclease programs.

Across Europe, the Middle East & Africa, a patchwork of regulatory regimes coexist alongside emerging public-private collaborations that prioritize agricultural biotechnology for food security and sustainable farming. These initiatives have created fertile ground for translational research partnerships, while strategic funding mechanisms are emerging to support early-stage functional genomics ventures. In the Asia-Pacific, government-led genome editing initiatives and large-scale agricultural modernization projects have rotated the spotlight onto both therapeutic and crop improvement applications, driving the establishment of regional centers of excellence and manufacturing hubs.

Spotlight on Leading Industry Innovators

A cadre of pioneering companies has staked leadership positions through differentiated nuclease platforms, proprietary delivery vectors, and robust IP portfolios. Some have advanced clinical-stage programs targeting genetic blood disorders, aligning strategic alliances with cell therapy manufacturers to create integrated R&D-to-commercialization pipelines. Others concentrate on reagent development and custom gene editing services, cultivating client relationships among academic and industrial researchers to secure recurring revenue streams.

Strategic acquisitions and collaborative licensing deals have further reshaped the competitive terrain, facilitating the cross-pollination of complementary technologies such as transcription activator-like effector nucleases and prime editing. These transactions underscore a shift toward consolidation, where scale and cross-platform compatibility become decisive factors in securing therapeutic partnerships and expanding market access.

Strategic Imperatives for Competitive Advantage

Leaders in the zinc finger nuclease space should prioritize investment in advanced delivery technologies that minimize immunogenicity and enhance tissue specificity. Establishing modular, scalable manufacturing processes will mitigate the impact of trade policy fluctuations and accelerate time to clinic. It is equally vital to foster consortium-based standardization efforts that reduce validation redundancies and streamline regulatory engagements.

Embracing data-driven optimization - leveraging bioinformatics to refine nuclease design and implementing real-time analytics during bioprocessing - will further elevate product quality and reduce development cycles. Additionally, cultivating multidisciplinary talent pools spanning molecular biology, bioengineering and regulatory science will underpin sustained innovation and ensure that organizations remain at the vanguard of genome editing capabilities.

Rigorous Framework Underpinning Our Analysis

This research integrates a multi-tiered methodology beginning with an exhaustive review of peer-reviewed literature, patent filings and industry reports to map technological trends and competitive positioning. Primary insights were garnered through in-depth interviews with senior R&D leaders, regulatory affairs experts and commercial strategists, ensuring that the analysis reflects both theoretical constructs and practical realities.

Quantitative data points were triangulated across multiple proprietary and public databases to validate market dynamics and segment performance. Where discrepancies arose, iterative consultations with subject-matter experts resolved inconsistencies and fortified confidence in the findings. The result is a robust analytical framework that balances empirical rigor with real-world applicability, designed to guide evidence-based decision-making in zinc finger nuclease initiatives.

Converging Insights and Future Outlook

The convergence of technological innovation, regulatory evolution and market forces has positioned zinc finger nucleases as a versatile and competitive platform in genome editing. From therapeutic breakthroughs targeting hematologic malignancies to agricultural enhancements that promise food security, the breadth of application areas continues to expand. While tariff-driven supply chain challenges underscore the importance of adaptable operating models, the overall trajectory remains one of disciplined growth fueled by collaboration and data-driven excellence.

By synthesizing segmentation insights, regional dynamics and competitive intelligence, this summary illuminates the strategic pathways that lead from molecular precision to real-world impact. The future of zinc finger nuclease technology will be defined by those organizations that marry cutting-edge science with operational resilience and a steadfast commitment to ethical and regulatory best practices.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Therapeutics
    • Chronic Diseases
    • Oncology
      • Hematologic Malignancies
      • Solid Tumors
    • Rare Genetic Disorders
  • Functional Genomics
    • Custom Services
    • Research Tools
      • Instruments
      • Reagents
  • Agriculture
    • Crop Improvement
      • Pest Resistance
      • Yield Enhancement
    • Livestock Engineering
  • Drug Discovery
    • Screening
      • Cell Based Assays
      • High Throughput Screening
    • Target Validation
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Sangamo Therapeutics, Inc.
  • Horizon Discovery Group plc
  • Cellectis SA
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc.
  • DuPont de Nemours, Inc.
  • ToolGen Inc.
  • Transposagen Biopharmaceuticals, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Zinc Finger Nuclease Technology Market, by Therapeutics
8.1. Introduction
8.2. Chronic Diseases
8.3. Oncology
8.3.1. Hematologic Malignancies
8.3.2. Solid Tumors
8.4. Rare Genetic Disorders
9. Zinc Finger Nuclease Technology Market, by Functional Genomics
9.1. Introduction
9.2. Custom Services
9.3. Research Tools
9.3.1. Instruments
9.3.2. Reagents
10. Zinc Finger Nuclease Technology Market, by Agriculture
10.1. Introduction
10.2. Crop Improvement
10.2.1. Pest Resistance
10.2.2. Yield Enhancement
10.3. Livestock Engineering
11. Zinc Finger Nuclease Technology Market, by Drug Discovery
11.1. Introduction
11.2. Screening
11.2.1. Cell Based Assays
11.2.2. High Throughput Screening
11.3. Target Validation
12. Americas Zinc Finger Nuclease Technology Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Zinc Finger Nuclease Technology Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Zinc Finger Nuclease Technology Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Sangamo Therapeutics, Inc.
15.3.2. Horizon Discovery Group plc
15.3.3. Cellectis SA
15.3.4. Thermo Fisher Scientific Inc.
15.3.5. Merck KGaA
15.3.6. GenScript Biotech Corporation
15.3.7. Integrated DNA Technologies, Inc.
15.3.8. DuPont de Nemours, Inc.
15.3.9. ToolGen Inc.
15.3.10. Transposagen Biopharmaceuticals, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ZINC FINGER NUCLEASE TECHNOLOGY MARKET MULTI-CURRENCY
FIGURE 2. ZINC FINGER NUCLEASE TECHNOLOGY MARKET MULTI-LANGUAGE
FIGURE 3. ZINC FINGER NUCLEASE TECHNOLOGY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ZINC FINGER NUCLEASE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ZINC FINGER NUCLEASE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ZINC FINGER NUCLEASE TECHNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RARE GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CUSTOM SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY PEST RESISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY YIELD ENHANCEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY LIVESTOCK ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CELL BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. CANADA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 50. CANADA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 51. CANADA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 52. CANADA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 53. CANADA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 54. CANADA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 55. CANADA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 56. CANADA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 57. MEXICO ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 58. MEXICO ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 59. MEXICO ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 60. MEXICO ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 63. MEXICO ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 64. MEXICO ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 98. GERMANY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 99. GERMANY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 100. GERMANY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 101. GERMANY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 102. GERMANY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 103. GERMANY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 104. GERMANY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 105. GERMANY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 106. FRANCE ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 107. FRANCE ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 108. FRANCE ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 109. FRANCE ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 110. FRANCE ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 111. FRANCE ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 112. FRANCE ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 113. FRANCE ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 122. ITALY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 123. ITALY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 124. ITALY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 125. ITALY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 126. ITALY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 127. ITALY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 128. ITALY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 129. ITALY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 130. SPAIN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 131. SPAIN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 132. SPAIN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 133. SPAIN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 134. SPAIN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 135. SPAIN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 136. SPAIN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 137. SPAIN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 146. SAUDI ARABIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 147. SAUDI ARABIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 148. SAUDI ARABIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 149. SAUDI ARABIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 150. SAUDI ARABIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 154. SOUTH AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 155. SOUTH AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 156. SOUTH AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 157. SOUTH AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 162. DENMARK ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 163. DENMARK ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 164. DENMARK ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 165. DENMARK ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 166. DENMARK ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 167. DENMARK ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 168. DENMARK ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 169. DENMARK ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 178. QATAR ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 179. QATAR ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 180. QATAR ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 181. QATAR ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 182. QATAR ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 183. QATAR ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 184. QATAR ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 185. QATAR ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 186. FINLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 187. FINLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 188. FINLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 189. FINLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 190. FINLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 191. FINLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 192. FINLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 193. FINLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 194. SWEDEN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 195. SWEDEN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 196. SWEDEN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 197. SWEDEN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 198. SWEDEN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 210. EGYPT ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 211. EGYPT ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 212. EGYPT ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 213. EGYPT ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 214. EGYPT ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 215. EGYPT ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 216. EGYPT ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 217. EGYPT ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 218. TURKEY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 219. TURKEY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 220. TURKEY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 221. TURKEY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 222. TURKEY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 224. TURKEY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 225. TURKEY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 226. ISRAEL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 227. ISRAEL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 228. ISRAEL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 234. NORWAY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 235. NORWAY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 236. NORWAY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 237. NORWAY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 238. NORWAY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 239. NORWAY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 240. NORWAY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 241. NORWAY ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 242. POLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 243. POLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 244. POLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 245. POLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 246. POLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 247. POLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 248. POLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 249. POLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 250. SWITZERLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 251. SWITZERLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 252. SWITZERLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 267. CHINA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 268. CHINA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 269. CHINA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 270. CHINA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 271. CHINA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 272. CHINA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 273. CHINA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 274. CHINA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 275. INDIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 276. INDIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 277. INDIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 278. INDIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 279. INDIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 280. INDIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 281. INDIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 282. INDIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 283. JAPAN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 284. JAPAN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 285. JAPAN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 286. JAPAN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 287. JAPAN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 288. JAPAN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 289. JAPAN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 290. JAPAN ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 291. AUSTRALIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 292. AUSTRALIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 293. AUSTRALIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 299. SOUTH KOREA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 300. SOUTH KOREA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 301. SOUTH KOREA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA ZINC FINGER NUCLEASE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA ZINC FINGER NUC

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Zinc Finger Nuclease Technology market report include:
  • Sangamo Therapeutics, Inc.
  • Horizon Discovery Group plc
  • Cellectis SA
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc.
  • DuPont de Nemours, Inc.
  • ToolGen Inc.
  • Transposagen Biopharmaceuticals, Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.11 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.98 Billion
Compound Annual Growth Rate22.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Broad Spectrum Non-restriction Nuclease Market by Application - Global Forecast to 2030 - Product Image

Broad Spectrum Non-restriction Nuclease Market by Application - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Food Enzymes Market by Type, Source, Application, Form, End Use - Global Forecast to 2030 - Product Image

Food Enzymes Market by Type, Source, Application, Form, End Use - Global Forecast to 2030

  • Report
  • 187 Pages
  • Global
From
Enzymes - Global Strategic Business Report - Product Image

Enzymes - Global Strategic Business Report

  • Report
  • 153 Pages
  • Global
From
Cas Nuclease Market Report 2025 - Product Image

Cas Nuclease Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Specialty Enzymes - Global Strategic Business Report - Product Image

Specialty Enzymes - Global Strategic Business Report

  • Report
  • 163 Pages
  • Global
From

About the Zinc Finger Nuclease Market

Zinc Finger Nucleases (ZFNs) are a type of engineered enzyme used in gene editing. They are composed of two parts: a zinc finger DNA-binding domain and a nuclease domain. The zinc finger domain binds to a specific sequence of DNA, while the nuclease domain cuts the DNA at that location. ZFNs are used to modify the genome of a cell, allowing researchers to study gene function and develop treatments for genetic diseases. ZFNs have been used in a variety of research applications, including gene therapy, gene knock-out, and gene knock-in. They have also been used to create animal models of human diseases, as well as to develop new crop varieties. The ZFN market is growing rapidly, driven by increasing demand for gene editing technologies. Companies in the market include Sangamo Therapeutics, Cellectis, Editas Medicine, and CRISPR Therapeutics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.